Stock 002399 SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Equities

002399

CNE100000P02

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
9.22 CNY +0.33% Intraday chart for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. +2.56% -21.40%
Apr. 02 Shenzhen Hepalink Receives Thai Approval for Blood Clot Drug Exarane MT
Apr. 02 Thailand Food and Drug Administration Approves for Sales in the Market of Exarane Produced by Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s Wholly-Owned Subsidiary Shenzhen Techdow Medicine Co., Ltd CI

Chart calendar Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

53c36b59b71722ff9d6fe800d585185.Pkfx6yYPM20pltLLhHFOov6VCbhhe4bknYdvoOlwEpg.BnWhvhJNYyxooLWp5zd9-MvvVuAxHfaQ2NMH-bEzf6lXNMaHRXp0LhH-iw~928a2b6ba51db29a7ac000298cf725a7

Upcoming events on Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

2024-04-28 Q1 2024 Earnings Release
2024-05-22 02:00 am Annual General Meeting
2024-08-27 Q2 2024 Earnings Release (Projected)
2024-10-29 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)
2025-05-05 Q1 2025 Earnings Release (Projected)

Past events on Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

2024-03-27 Q4 2023 Earnings Release
2024-01-10 01:00 am Extraordinary Shareholders Meeting
2023-12-15 01:00 am Extraordinary Shareholders Meeting
2023-10-29 Q3 2023 Earnings Release
2023-08-29 Q2 2023 Earnings Release
2023-05-22 02:00 am Annual General Meeting
2023-04-27 Q1 2023 Earnings Release
2023-03-29 Q4 2022 Earnings Release
2022-11-04 02:30 am Extraordinary Shareholders Meeting
2022-10-27 Q3 2022 Earnings Release
2022-08-28 Interim 2022 Earnings Release
2022-06-10 02:30 am Annual General Meeting
2022-04-28 Q1 2022 Earnings Release
2022-04-10 FY 2021 Earnings Release
2022-01-03 Extraordinary Shareholders Meeting
2021-10-27 Q3 2021 Earnings Release
2021-09-28 02:30 am Extraordinary Shareholders Meeting
2021-08-26 Interim 2021 Earnings Release
2021-05-26 02:30 am Annual General Meeting
2021-04-28 Q1 2021 Earnings Release

Past dividends on Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

2023-07-17 Annual 0.1 CNY
2022-07-27 Annual 0.035 CNY
2021-07-05 Annual 0.15 CNY
2020-06-30 Annual 0.18 CNY
2019-07-14 Annual 0.1 CNY
2018-07-01 Annual 0.045 CNY
2017-06-27 Annual 0.25 CNY
2016-06-12 Annual 0.6 CNY
2015-06-08 0.3 CNY
2014-06-08 Annual 0.3 CNY

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CNY		Released
Forecast
Spread 		4 625
5 521
-16.24%		5 332
5 755
-7.35%		6 365
6 323
0.66%		7 159
7 354
-2.64%		5 446
5 528
-1.5%
5 938

EBITDA
Million CNY		Released
Forecast
Spread 		0,00
0,00
- 		1 607
1 480
8.56%		502
1 315
-61.82%		1 387
1 353
2.58%		-510
834
-161.12%
926

EBIT
Million CNY		Released
Forecast
Spread 		1 315
889
47.89%		1 330
1 206
10.26%		926
1 046
-11.42%		829
1 107
-25.14%		-861
617
-239.54%
767

Earnings before Tax (EBT)
Million CNY		Released
Forecast
Spread 		1 315
948
38.71%		1 328
1 100
20.71%		222
1 037
-78.57%		830
1 095
-24.21%		-928
277
-434.58%
767

Net income
Million CNY		Released
Forecast
Spread 		1 059
898
17.97%		1 024
913
12.19%		241
810
-70.27%		727
990
-26.53%		-783
199
-494.14%
649

EPS
CNY		Released
Forecast
Spread 		0,85
0,72
17.97%		0,76
0,62
22.06%		0,16
0,55
-70.16%		0,50
0,67
-26.04%		-0,53
0,36
-248.28%
0,44

Announcement Date28/02/2029/03/2130/03/2229/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million CNY		Released
Forecast
Spread 		1 791
1 620
10.59%		1 910
1 507
26.79%		1 846
1 898
-2.74%		1 637
1 855
-11.76%		1 756
1 787
-1.73%		1 301
1 644
-20.84%		1 405
2 009
-30.05%		1 350
1 478
-8.64%		1 368
1 495
-8.5%
EBIT
Million CNY		Released
Forecast
Spread 		165
300
-45%		283
224
26.63%
259

212
345
-38.48%		234
215
8.62%		73,6
205
-64.09%
294


137


135

Announcement Date30/03/2229/04/2229/08/2228/10/2229/03/2328/04/2330/08/2330/10/2328/03/24

Upcoming sector events for Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

2024-04-28 CHONGQING PHARSCIN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28 SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.: Q1 2024 Earnings Release
2024-04-29 SINOTHERAPEUTICS INC.: Q4 2023 Earnings Release
2024-04-29 KUNMING LONGJIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 OTSUKA HOLDINGS CO., LTD.: Q1 2024 Earnings Release
2024-04-29 YIFAN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-29 HANMI PHARM. CO., LTD.: Q1 2024 Earnings Release
2024-05-01 AJANTA PHARMA LIMITED: Q4 2024 Earnings Release (Projected)
2024-05-01 PROCTER & GAMBLE HEALTH LIMITED: Q3 2024 Earnings Release (Projected)
2024-05-06 SANDOZ GROUP AG: Q1 2024 Sales and Revenue Release
More events

Past sector events for Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Today HYBIO PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today APICHOPE PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
Today YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.: Q1 2024 Earnings Release
Today HARBIN GLORIA PHARMACEUTICALS CO., LTD: Q1 2024 Earnings Release
Today SHANGHAI HAIXIN GROUP CO., LTD.: Q1 2024 Earnings Release
Today ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
Today YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.: Q4 2023 Earnings Release
Today HYBIO PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-25 SINOTHERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002399 Stock
  4. Calendar Shenzhen Hepalink Pharmaceutical Group Co., Ltd.